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The binding of 12sI-melatonin, a potent analog of melatonin, to rat brain synaptosomal preparations was 
investigated. lZSI-melatonin bound with high affinity (& = 38 nM) to a single class of sites (B,,,= = 81 fmol/mg 
protein). Kinetic studies indicated that binding was time-dependent and reversible. Specific lZSI-melatonin 
binding was inhibited by melatonin, and was unaffected by other structurally related compounds including 
serotonin. Binding of iz51-melatonin was greatly reduced if the synaptosomal preparations were pretreated 
by heat or trypsin but was unaffected by freeze-thawing. These results suggest hat l*9-melatonin may serve 
as a valuable probe for studying melatonin receptors. 
Melatonin Receptor (Brain) 
1. INTRODUCTION 
A large body of evidence supports the notion 
that the pineal gland and its major product, mela- 
tonin, play a role in coordinating mammalian 
reproduction [l], but the mode of action of the 
hormone is unclear. We have recently shown that 
melatonin inhibits the stimulated release of dopa- 
mine from rat hypothalamus in vitro [2], by the 
reduction of Ca2+ entry into the presynaptic nerve 
endings [3]. The effect of melatonin on dopamine 
release varied significantly within the various brain 
regions [4], and was dependent on the prevailing 
cyclical stage of the animal [5] and on the circadian 
time [6]. These phenomena were compatible with 
the existence of melatonin receptors in the brain. 
The characterization of melatonin receptors has 
been limited due to the unavailability of adequate 
receptor probes. The existence of high-affinity 
binding sites for [3H]melatonin in membrane and 
cytosolic fractions of brain and peripheral tissues 
has been reported [7,8]. However, the findings are 
incomplete and sometimes conflicting, and there 
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are difficulties in replicating these studies using the 
presently available [3H]melatonin. We have recent- 
ly observed that iodomelatonin could mimic the ef- 
fects of melatonin in inhibiting the evoked release 
of dopamine from rat hypothalamus in vitro (to be 
described elsewhere). Here we describe the binding 
of radiolabeled iodomelatonin to synaptosomal 
preparations from rat brain. 
2. MATERIALS AND METHODS 
1251-melatonin was prepared by iodination of 
melatonin with “‘1 (Amersham) (20 Ci/mmol) in 
the presence of Iodo-Gen. The principal iodination 
product, 2-[1251]iodomelatonin was separated from 
unsubstituted melatonin and purified by TLC as 
described by Vakkuri et al. [9]. Melatonin, sero-’ 
tonin, S-hydroxyindoleacetic acid, 5methoxytryp- 
tamine and N-acetylserotonin were purchased 
from Sigma. 
Male rats of the CD strain (3-4 months old, 
weighing 190-250 g) were maintained on a 14 h 
light: 10 h dark schedule (lights on at 05.00 h). 
Food and water were supplied ad libitum. The rats 
were decapitated (between 09.00 and 11.00 h), 
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their brains rapidly removed and suspended in 10 Specific binding was defined as that displaced by 
vols ice-cold 0.32 M sucrose. Crude synaptosomal 5OgM non-radioactive melatonin and ranged from 
pellets were prepared as described [7] and suspend- 50 to 60% of the total binding at 20 nM 1251- 
ed in 2 vols of 50 mM Tris-HCl buffer, pH 7.4, melatonin. Analysis of the equilibrium binding 
containing 4 mM CaCl2. Protein content was data was performed utilizing a distribution-free 
determined according to Matkwell et al. [lo] with computer method fll] as well as traditional 
bovine serum albumin (Sigma) as a standard, graphical methods [ 121. 
Aliquots of the synaptosomal preparations (200 
yg protein/20 ~1) were incubated with 40 ,& Tris 
buffer containing 5-50 nM ‘251-melatonin for O-30 
min at 37°C on a shaking water bath, in the ab- 
sence or presence of unlabeled melatonin (SO PM). 
Membranes were then collected by vacuum filtra- 
tion using GF/C glass fiber filters and washed with 
3 x4 ml buffer at 4°C. The filters containing 
bound 1251-melatonin were assayed for radioactivity 
using a Packard gamma counter. All samples were 
run in duplicates and each experiment repeated 4 
times, using different batches of “251-melatonin. 
In some experiments, the synaptosomal prepara- 
tions were pretreated by heat (WC, 10 min), with 
trypsin (0.1 mg/ml trypsin, 22”C, 10 min) or freez- 
ing ( -20°C, 24 h) and thawing prior to the 
binding assay. 
3. RESULTS AND DISCUSSION 
3.1. Equilibrium studies 
The concentration dependence of *251-melatonin 
binding to rat brain synaptosomal preparations 
was investigated (fig. 1). Specific binding at equi- 
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Fig.1. i251-melatordn binding to rat brain synaptosomal preparations as a function of ‘25f-melatonin concentration. (A) 
Specific binding was determined at equilibrium (30 mire jucubations). The soIid Iine is a theoreticaf ine reconstructed 
from the Kd and V,,, vaIues obtained by ~stribu~ion-free analysis of the data. (B) Scatchard plot of the specific “% 
melatonin-binding data. The line drawn represents the best fit assuming a single class of sites; the Kd and Bmax values 
obtained are the same as in A. (C) Hill plot of the same data. The value of Bma, obtained from the Scatchard analysis 
was used. 
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librium increased greatly at low and slightfy at 
higher concentrations of ~2~i*melatonin approach- 
ing saturation (fig.lA). Scatchard analysis of the 
equilibrium experiments uggested that there is on- 
ly a single class of binding sites for ‘251-melatonin 
(fig.lB). Distribution-free analysis of the data in- 
dicated that r2’I-melatonin was bound with a 
dissociation constant (&I) of 38.7 If: 2.0 nM and a 
number of binding sites at saturation (B,,& of 
81 f 14 fmol/mg protein (fig.lA,B). Analysis of 
the binding data according to the Hill equation 
(fig.lC) yielded a Hill coefficient of 1.00 tO.05, 
thus indicating a non-cooperative binding mode 
(fig.2C). Thus, the binding capacity for i251- 
melatonin in rat brain synaptosomes (81 nmoi/mg 
protein) is very similar to that reported for 
A 
Fig.2. Time courses of ‘z51-melaton~u association with 
(Al and dissociation from (B) synaptosoma1 
preparations. (A) Synaptosomes were incubated with 20 
nM ‘Z51-melatonin for the indicated times. Inset: 
association is plotted according to a pseudo-first-order 
equation [12]. (B) Following equilibration with % 
meiatonin (40 nM, 30 min) a 1OWfo~d excess of 
meiatonin was added and the amount of specifieaity 
bound i~51-me~atonin remaining at the indicated times 
was determined. Inset: first-order plot of the 
dissociation data. 
~~Hlmelatonin-binding sites in these preparations 
(i.e. 62-94 fmoilmg protein [7]). 
Freeze-thawing of the synaptdsomai prepara- 
tions had no effect on the binding of ““I-melato- 
nin. Heat and trypsin treatment abolished almost 
all specific binding (not shown). These data sug- 
gested that ‘251-melatonin was bound to a synap- 
tosomai membrane-associated protein. 
3.2. Kinetic studies 
Fig.2A shows the association of “~1-melato~n 
with the synaptosomai preparations. Specific 
binding increased during the first 15 min and 
equilibrated after approx. 20 min. The association 
rate constant (kr = 1.82 x lo6 min-’ . M-‘) was 
determined from the pseudo-first-order plot of the 
time course (fig.2A, inset). Following equilibration 
with 40 nM 1z51-melatonin for 30 min at 37”C, a 
IOOO- fold excess of melatonin was added. 
Displacement of all specific binding of ‘291-meIa- 
tonin occurred within 30 min (fig.2B) indicating 
that the specific binding of ‘251-melatonin to the 
synaptosomal preparations was reversible. The 
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Fig.3. l~bibition of ‘2SI-meIatonin (40 nM) binding to 
synaptosomai preparations by different concentrations 
of indole derivatives. Synaptosomes were incubated for 
30 min with ‘2SI-melatonin in the presence of different 
concentrations of melatonin (+), 5-hydroxyindoie- 
acetic acid (m), 5-hydroxytry~tam~ne (serotonin) fo), 
~a~ty~serotonin (01, 5-m~thoxytry~tamin~ (A.). The 
specific binding of ‘~~I-m~Iatonin was obtained by 
subtracting the binding observed in the presence of 50 
f&l iodomelatonin. 
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d~ss~~i~tion rate constant (k- 1 = 0.082 min-‘) 
was calculated from the slope of the first-order 
plot of these data (fig. 2B, inset). The kinetically 
derived value of & (45.0 nM) obtained from the 
ratio of rate constants, k- r/ki, was in a very good 
agreement with that determined from equilibrium 
experiments (38.7 nM, fig.i). This suggested that 
‘251-melatonin binding followed mass action prin- 
ciples for a simple bimolecular reaction. 
3 * 3 * ~~~~~~C~~~# 
The ability of various indole compounds to in- 
hibit 125~-melatonin bi ding was investigated (fig. 
3). Melatonin inhibited iodomelatonin binding in a 
dose-dependent manner. The concentrations of 
melatonin which inhibited the binding of iz51- 
melatonin (40 nM) by 33 and 50% at ~uilibri~m 
were I50 and 700 nM, respectivdy. Hence, the 
equilibrium dissociation constant of melatonin 
binding to these sites could be estimated at 1.50-350 
nM. This value is 2-5-fold larger than that 
reportedly obtained using [3HJmelatonin as a 
probe (- 75 nM [7])_ Metatonin was the most 
potent of the indole compound tested in displaying 
‘251-melatonin from the synaptosomal prepara- 
tions; 5-hydroxyindoleacetic acid and serotonin 
were far less potent (fig.3). These results indicated 
that the specificity for melatonin of itSI- 
melatonin-binding sites was much higher than that 
of the previously reported [3H]melatonin-binding 
sites [7,8]. 
The use of iz51-melatonin as a melatonin recep- 
tor probe has several advantages: (i) time-depen- 
dent, reversible, binding to a single class of non- 
cooperative sites; (ii) high specificity for mela- 
tonin; (iii) absence of radiolig~d instability 
problems; (iv) high specific activity; (v) expensive 
and cumbersome scintillation mounting can be 
avoided. These advantages make the use of *251- 
melatonin a valuable tool in the study of melatonin 
receptors. 
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